Neonatal hypoglycaemia following maternal olanzapine therapy during pregnancy: A case report

Therapeutic Advances in Psychopharmacology

Volumn 2, Issue 6, 2012, Pages 265-268

  Rowe, Melissa ^a   Gowda, Bharath A ^a   Taylor, David ^a   Hannam, Simon ^b   Howard, Louise M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROTHIAZIDE; DIAZEPAM; DIAZOXIDE; FOLIC ACID; GLUCOSE; LITHIUM; OLANZAPINE; PROMETHAZINE; VALPROIC ACID;

ADULT; AFRICAN AMERICAN; ALCOHOLISM; APGAR SCORE; ARTICLE; BIPOLAR I DISORDER; BODY MASS; CANNABIS ADDICTION; CARDIOTOCOGRAPH; CASE REPORT; CESAREAN SECTION; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; DRUG DOSE INCREASE; DRUG WITHDRAWAL; FEMALE; FETUS ECHOGRAPHY; GESTATIONAL AGE; GRANDIOSE DELUSION; HOSPITAL ADMISSION; HUMAN; HYPOGLYCEMIA; INFANT; INTRAUTERINE GROWTH RETARDATION; IRRITABILITY; MALE; NEONATAL HYPOGLYCEMIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANOIA; PATIENT COMPLIANCE; PREGNANCY; PRENATAL GROWTH; PRIORITY JOURNAL; RECURRENT DISEASE; SMALL FOR DATE INFANT; UNPLANNED PREGNANCY;

EID: 84997880625     PISSN: 20451253     EISSN: 20451261     Source Type: Journal    
DOI: 10.1177/2045125312460395     Document Type: Letter

References (16)

1. Babu G. Desai G. Tippeswamy H. Chandra P. (2010) Birth weight and use of olanzapine in pregnancy: a prospective comparative study. J Clin Psychopharmacol 30: 331–332.
2. Barrett C. Richens A. (2003) Epilepsy and pregnancy: report of an Epilepsy Research Foundation Workshop. Epilepsy Res 52: 147–187.
3. Boden R. Lundgren M. Brandt L. Reutfors J. Kieler H. (2012) Antipsychotics during pregnancy: relation to fetal and maternal metabolic effects antipsychotics during pregnancy. Arch Gen Psychiatry 69: 715–721.
4. Coban D. Kurtoğlu S. Akın M. Akçakuş M. Güneş T. (2010) Neonatal episodic hypoglycemia: a finding of valproic Acid withdrawal. J Clin Res Pediatr Endocrinol 2: 92–94.
5. Ebenbichler C. Laimer M. Eder U. Mangweth B. Weiss E. Hofer A. et al. (2003) Olanzapine induces insulin resistance: results from a prospective study. J Clin Psychiatry 64: 1436–1439.
6. Howard L. Webb R. Abel K. (2004) Safety of antipsychotic drugs for pregnant and breastfeeding women with non-affective psychosis. BMJ 329: 933–934.
7. Kahn B. Flier J. (2000) Obesity and insulin resistance. J Clin Invest 106: 473–481.
8. Kulkarni J. McCauley-Elsom K. Marston N. Gilbert H. Gurvich C. de Castella A. et al. (2008) Preliminary findings from the National Register of Antipsychotic Medication in Pregnancy. Aust N Z J Psychiatry 42: 38–44.
9. MacRitchie K. Young A. McElhatton P. (2006) Birth outcome following therapeutic atypical antipsychotic exposure during pregnancy. Clin Toxicol 44: A84.
10. McIntyre R. McElroy S. Eudicone J. Forbes R. Carlson B. Baker R. (2011) A 52-week, double-blind evaluation of the metabolic effects of aripiprazole and lithium in bipolar I disorder. Prim Care Companion CNS Disord 13. Doi: 10.4088/PCC.11m01182.
11. McKenna K. Koren G. Tetelbaum M. Wilton L. Shakir S. Diav-Citrin O. et al. (2005) Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry 66: 444–449; quiz 546.
12. Newham J. Thomas S. MacRitchie K. McElhatton P. McAllister-Williams R. (2008) Birth weight of infants after maternal exposure to typical and atypical antipsychotics: prospective comparison study. Br J Psychiatry 192: 333–337.
13. Newport D. Calamaras M. DeVane C. Donovan J. Beach A. Winn S. et al. (2007) Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes. Am J Psychiatry 164: 1214–1220.
14. Reis M. Kallen B. (2008) Maternal use of antipsychotics in early pregnancy and delivery outcome. J Clin Psychopharmacol 28: 279–288.
15. Stanley C. Baker L. (1999) The causes of neonatal hypoglycemia. N Engl J Med 340: 1200–1201.
16. Victoriano M. de Beaurepaire R. Naour N. Guerre-Millo M. Quignard-Boulangé A. Huneau J. et al. (2010) Olanzapine-induced accumulation of adipose tissue is associated with an inflammatory state. Brain Res 1350: 167–175.